BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 24053417)

  • 1. Snapshot of transurethral resection of bladder tumours in the United Kingdom Audit (STUKA).
    Gan C; Patel A; Fowler S; Catto J; Rosario D; O'Brien T
    BJU Int; 2013 Nov; 112(7):930-5. PubMed ID: 24053417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-life Experience: Early Recurrence With Hexvix Photodynamic Diagnosis-assisted Transurethral Resection of Bladder Tumour vs Good-quality White Light TURBT in New Non-muscle-invasive Bladder Cancer.
    Mariappan P; Rai B; El-Mokadem I; Anderson CH; Lee H; Stewart S; Donat R
    Urology; 2015 Aug; 86(2):327-31. PubMed ID: 26142924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced Quality and Effectiveness of Transurethral Resection of Bladder Tumour in Non-muscle-invasive Bladder Cancer: A Multicentre Real-world Experience from Scotland's Quality Performance Indicators Programme.
    Mariappan P; Johnston A; Padovani L; Clark E; Trail M; Hamid S; Hollins G; Simpson H; Thomas BG; Hasan R; Bhatt J; Ahmad I; Nandwani GM; Mitchell IDC; Hendry D;
    Eur Urol; 2020 Oct; 78(4):520-530. PubMed ID: 32690321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and Its Clinical Impact on the Management of High-risk Non-muscle-invasive Bladder Cancer Patients Candidate for Repeated Transurethral Resection.
    Del Giudice F; Barchetti G; De Berardinis E; Pecoraro M; Salvo V; Simone G; Sciarra A; Leonardo C; Gallucci M; Catalano C; Catto JWF; Panebianco V
    Eur Urol; 2020 Jan; 77(1):101-109. PubMed ID: 31699526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Good quality white-light transurethral resection of bladder tumours (GQ-WLTURBT) with experienced surgeons performing complete resections and obtaining detrusor muscle reduces early recurrence in new non-muscle-invasive bladder cancer: validation across time and place and recommendation for benchmarking.
    Mariappan P; Finney SM; Head E; Somani BK; Zachou A; Smith G; Mishriki SF; N'Dow J; Grigor KM;
    BJU Int; 2012 Jun; 109(11):1666-73. PubMed ID: 22044434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of extended transurethral resection of bladder tumour (TURBT) in the treatment of bladder cancer.
    Richterstetter M; Wullich B; Amann K; Haeberle L; Engehausen DG; Goebell PJ; Krause FS
    BJU Int; 2012 Jul; 110(2 Pt 2):E76-9. PubMed ID: 22313727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of immediate radical cystectomy in the treatment of patients with residual T1 bladder cancer on restaging transurethral resection.
    Sternberg IA; Keren Paz GE; Chen LY; Herr HW; Dalbagni G
    BJU Int; 2013 Jul; 112(1):54-9. PubMed ID: 23146082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How well do we manage non-muscle invasive bladder tumors? A UK audit of real-life practices.
    Sountoulides P; Mutomba WF; Bouras E; Lim J; Bourdoumis A; Jain A
    Urologia; 2020 Aug; 87(3):142-148. PubMed ID: 31959070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective randomized trial of hexylaminolevulinate photodynamic-assisted transurethral resection of bladder tumour (TURBT) plus single-shot intravesical mitomycin C vs conventional white-light TURBT plus mitomycin C in newly presenting non-muscle-invasive bladder cancer.
    O'Brien T; Ray E; Chatterton K; Khan MS; Chandra A; Thomas K
    BJU Int; 2013 Dec; 112(8):1096-104. PubMed ID: 24053153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EFFICACY OF DIFFERENT RESECTIONS ON NON-MUSCLE-INVASIVE BLADDER CANCER AND ANALYSIS OF THE OPTIMAL SURGICAL METHOD.
    Chen GF; Shi TP; Wang BJ; Wang XY; Zang Q
    J Biol Regul Homeost Agents; 2015; 29(2):465-70. PubMed ID: 26122238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized controlled study of the efficacy and safety of continuous saline bladder irrigation after transurethral resection for the treatment of non-muscle-invasive bladder cancer.
    Onishi T; Sugino Y; Shibahara T; Masui S; Yabana T; Sasaki T
    BJU Int; 2017 Feb; 119(2):276-282. PubMed ID: 27444991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing the short-term outcomes and complications of monopolar and bipolar transurethral resection of non-muscle invasive bladder cancers: a prospective, randomized, controlled study.
    Bolat D; Gunlusoy B; Degirmenci T; Ceylan Y; Polat S; Aydin E; Aydogdu O; Kozacioglu Z
    Arch Esp Urol; 2016 Jun; 69(5):225-33. PubMed ID: 27291558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of transurethral resection of bladder tumor: analysis of cystectomy specimens to evaluate for residual tumor.
    Lee SE; Jeong IG; Ku JH; Kwak C; Lee E; Jeong JS
    Urology; 2004 May; 63(5):873-7; discussion 877. PubMed ID: 15134968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electromotive instillation of mitomycin immediately before transurethral resection for patients with primary urothelial non-muscle invasive bladder cancer: a randomised controlled trial.
    Di Stasi SM; Valenti M; Verri C; Liberati E; Giurioli A; Leprini G; Masedu F; Ricci AR; Micali F; Vespasiani G
    Lancet Oncol; 2011 Sep; 12(9):871-9. PubMed ID: 21831711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transurethral en bloc submucosal hydrodissection vs conventional resection for resection of non-muscle-invasive bladder cancer (HYBRIDBLUE): a randomised, multicentre trial.
    Gakis G; Karl A; Bertz S; Burger M; Fritsche HM; Hartmann A; Jokisch F; Kempkensteffen C; Miller K; Mundhenk J; Schneevoigt BS; Schubert T; Schwentner C; Wullich B; Stenzl A
    BJU Int; 2020 Oct; 126(4):509-519. PubMed ID: 32578332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hospitalization for transurethral bladder resection reduces quality of life in Danish patients with non-muscle-invasive bladder tumour.
    Mogensen K; Christensen KB; Vrang ML; Hermann GG
    Scand J Urol; 2016 Jun; 50(3):170-4. PubMed ID: 26817989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The significance of lymphovascular invasion in transurethral resection of bladder tumour and cystectomy specimens on the survival of patients with urothelial bladder cancer.
    Streeper NM; Simons CM; Konety BR; Muirhead DM; Williams RD; O'Donnell MA; Joudi FN
    BJU Int; 2009 Feb; 103(4):475-9. PubMed ID: 18990174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of photodynamic diagnosis-assisted transurethral resection of bladder tumors on the prognostic outcome after radical cystectomy: results from PROMETRICS 2011.
    May M; Fritsche HM; Vetterlein MW; Bastian PJ; Gierth M; Nuhn P; Aziz A; Fisch M; Stief CG; Hohenfellner M; Wirth MP; Novotny V; Hakenberg OW; Noldus J; Gilfrich C; Bolenz C; Burger M; Brookman-May SD;
    World J Urol; 2017 Feb; 35(2):245-250. PubMed ID: 27300339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perioperative outcomes of transurethral resection for t1 bladder tumors: quality evaluation based on patient, tumor and surgeon criteria.
    Bebane S; Denize J; Goujon A; Meria P; Verine J; Mongiat-Artus P; Desgrandchamps F; Masson-Lecomte A
    World J Urol; 2021 Nov; 39(11):4159-4165. PubMed ID: 34160681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An International Collaborative Consensus Statement on En Bloc Resection of Bladder Tumour Incorporating Two Systematic Reviews, a Two-round Delphi Survey, and a Consensus Meeting.
    Teoh JY; MacLennan S; Chan VW; Miki J; Lee HY; Chiong E; Lee LS; Wei Y; Yuan Y; Yu CP; Chow WK; Poon DM; Chan R; Lai F; Ng CF; Breda A; Kramer MW; Malavaud B; Mostafid H; Herrmann T; Babjuk M
    Eur Urol; 2020 Oct; 78(4):546-569. PubMed ID: 32389447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.